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In this issue of the Journal, Mueller and colleagues1 report on their expe-rience with postoperative atrial arrhythmias in a series of 183 patients whounderwent isolated single coronary artery bypass grafting (CABG) with theleft internal thoracic artery placed to the left anterior descending coronaryartery. The authors observed that the prevalence of postoperative atrialarrhythmias was similar, at approximately 18% to 22%, for patients having
conventional CABG and for those having beating-heart operations. With the devel-
opment and growing acceptance of technologies that facilitate less invasive ap-
proaches for CABG, several recent, but conflicting, reports have been published on
the frequency of this complication.2-12 In light of an appreciable change in the
current practice of CABG, and the conflicting information regarding postoperative
atrial fibrillation, it would be useful to reflect on what is presently known about this
complication and the most appropriate direction for our future efforts in this area.
Large-scale longitudinal studies have demonstrated that atrial fibrillation is the
most common arrhythmia in the general population.13,14 The prevalence of this
arrhythmia increases with age, with a prevalence of less than 1% at age 50 but more
than 9% to 10% at age 80.13 Other risk factors in the general population include
congestive heart failure, valvular heart disease, hypertension, diabetes, and a history
of myocardial infarction. Given these predisposing factors, it is not surprising that
this arrhythmia is a common complication in the adult population having cardiac
surgery.
Atrial arrhythmias have been recognized as a common postoperative complica-
tion since the earliest days of CABG. These arrhythmias include atrial fibrillation,
atrial flutter, and paroxysmal atrial tachycardia. Clinical studies have reported a
prevalence of 25% to 40% among patients undergoing CABG, with a peak incidence
occurring between the second and fourth days after the operation.15 This rate is even
higher for patients undergoing valve replacement, either alone or in combination
with CABG. For most patients, postoperative atrial arrhythmias are a benign
complication, without significant morbidity. Nonetheless, there is ample evidence
that they are associated with adverse outcomes, including patient discomfort or
anxiety, the need for extra medications or treatments, the possibility of thrombo-
embolic complications, and both increased hospital length of stay and hospital
costs.16-18 There are few data regarding the post-hospital discharge course of
patients with this complication, but it is generally believed that the risk of this
arrhythmia decreases substantially within the first month after surgery. It is impor-
tant to remember that in an era of early hospital discharge, often on the third or
fourth postoperative day, these arrhythmias may occur after discharge and patients
should be counseled appropriately.
The treatment of patients with postoperative atrial arrhythmias has not been
standardized despite many years of clinical experience and investigation. Direct-
current cardioversion is highly effective for restoring sinus rhythm in most patients,
but this procedure is typically reserved for patients with hemodynamic instability. In
clinical practice, most patients are treated medically for their arrhythmias. There are
two goals of pharmacologic therapy: (1) control of the heart rate and (2) conversion
to a sinus rhythm. Medications such as diltiazem, -blockers, or digoxin can be used
effectively to control the heart rate, and drugs such as sotalol, amiodarone, ibutilide,
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procainamide, and quinidine, among others, can be used to
restore sinus rhythm. Each of these agents may be most
appropriate for certain patient groups, and all require spe-
cific monitoring during treatment (ie, Q-T interval, serum
levels). Because pharmacologic therapy and/or cardiover-
sion are so effective, nearly all patients can be discharged in
sinus rhythm. For patients in whom sinus rhythm cannot be
restored, adequate heart rate control and anticoagulation
with warfarin sodium (Coumadin) are appropriate.
The pathogenesis of postoperative atrial arrhythmias is
not completely understood. On the basis of experimental
models, an underlying electrophysiologic abnormality is a
necessary substrate for these arrhythmias.19 A nonuniform
dispersion of refractoriness in the atrial tissue can set up
local areas of functional block. These can be established
simply by the process of aging (ie, progressive fibrosis of
the atrial tissue) or long-standing volume overload, but may
also be affected by events inherent in conventional cardiac
surgical procedures (ie, ischemia during cardioplegic arrest,
cannulation technique) or by changes that might occur after
any type of surgical procedure (ie, alterations in autonomic
tone). Regardless of how the substrate is established, an
initiating premature atrial contraction is also required to
begin the arrhythmia. From a theoretical standpoint, patients
undergoing beating-heart CABG would not be subject to
some of these precipitating factors (ie, atrial ischemia, can-
nulation techniques) but would still be subject to others (ie,
alterations in autonomic tone). Unfortunately, our limited
knowledge of the pathogenesis and underlying mechanisms
of these arrhythmias has precluded the development of
specific therapies to prevent their occurrence.
A variety of strategies have been proposed over the years
to reduce the frequency of postoperative atrial arrhythmias.
Although numerous studies of pharmacologic agents have
been reported, the results have often been conflicting.20-24
The most compelling evidence supports the use of -block-
ers postoperatively to reduce the frequency of these arrhyth-
mias.20 Moreover, -blocker withdrawal should be avoided
because this practice is associated with an increase in the
frequency of these arrhythmias. The use of other drugs is
more controversial. Used prophylactically, the administra-
tion of digoxin or supplementation with magnesium does
not appear to be effective.21,22 Calcium channel blockers,
particularly verapamil, can be associated with adverse he-
modynamic effects and are not effective for this purpose.
The prophylactic use of type Ia agents (ie, procainamide,
quinidine) in this setting has not been studied extensively,
and they are rarely used by surgeons. The use of type Ic
antiarrhythmic agents (ie, sotalol, amiodarone) has shown
promise for at least some patient subgroups in several recent
small studies. Amiodarone, administered for several days
before the operation, or sotalol, used in low doses postop-
eratively, both appear to reduce the frequency of postoper-
ative atrial arrhythmias.23,24 Further studies are clearly
needed in this area.
Nonpharmacologic strategies may also be useful for pre-
venting this complication. A variety of pacing strategies
have been proposed in the early postoperative period to
reduce the number of premature atrial contractions, but
these approaches have produced only limited success in
reducing the prevalence of postoperative atrial arrhyth-
mias.25 The maze procedure is very effective for preventing
these arrhythmias, but the addition of this procedure carries
a finite risk of additional morbidity and mortality and has
been reserved for highly selected patients with preoperative
chronic atrial fibrillation. Newer approaches involving a
more limited “maze-like” procedure, including targeted iso-
lation of anatomic substrates, such as the pulmonary veins,
may have some applicability in the future26 if they can be
made less invasive and easy to perform. However, their
development awaits a clearer mechanistic understanding of
the necessary substrate required for the initiation of these
arrhythmias.
In the year 2000, up to 20% of all CABG operations were
performed with a “less invasive” approach. Several ap-
proaches that avoid the use of cardiopulmonary bypass are
currently available, including minimally invasive direct cor-
onary artery bypass (MIDCAB) using a mini-thoracotomy
incision, off-pump coronary artery bypass (OPCAB) using a
conventional sternotomy incision, and endoscopic ap-
proaches. Each of these operations can be accomplished
with the aid of a variety of stabilization devices, bypass
conduits, and anesthetic techniques. On the basis of the
technical details of these operations, this is obviously a
heterogeneous group of patients. Not surprisingly, the liter-
ature is replete with conflicting information regarding the
incidence of postoperative atrial arrhythmias after mini-
mally invasive CABG. In a retrospective, nonrandomized
survey, Buffolo and colleagues2 reported significantly fewer
arrhythmias (atrial and ventricular) among patients who
underwent OPCAB. Chauhan and colleagues3 reported a
lower prevalence of postoperative atrial arrhythmias in a
small number of patients who underwent MIDCAB proce-
dures than among those who underwent conventional
CABG procedures. Allen and colleagues4 reported no post-
operative atrial arrhythmias in a small group of patients who
underwent single-vessel redo CABG with the left internal
thoracic artery to the left anterior descending coronary
artery using a MIDCAB approach. Subramanian, McCabe,
and Geller5 reported that postoperative atrial fibrillation
developed in 8% of patients (14/185) undergoing a MID-
CAB operation.
There are an equal number of negative studies showing
no difference in the incidence of postoperative atrial ar-
rhythmias. Cohn, Sirois, and Johnson6 reported a small
case-control study in which there was no difference in the
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frequency of postoperative atrial arrhythmias for patients
who underwent MIDCAB and those who underwent con-
ventional CABG. Other “negative” studies were reported by
Abreu,7 Saatvedt,9 Siebert,10 and their colleagues. Each of
these studies involved small numbers of patients in the
groups not having cardiopulmonary bypass. The small, ret-
rospective, nonrandomized study by Mueller and col-
leagues1 in this issue of the Journal reports similar findings.
In another retrospective review, Tamis-Holland and col-
leagues11 reported a lower frequency of postoperative atrial
arrhythmias among patients undergoing MIDCAB proce-
dures compared with those undergoing conventional
CABG, but they attributed this finding to underlying differ-
ences in the two patient groups. Unfortunately, most of
these studies were nonrandomized, retrospective case re-
ports. All of these studies can be criticized for not compar-
ing identical patient groups undergoing conventional versus
less invasive CABG.
The most compelling evidence for a lower frequency of
postoperative atrial arrhythmias comes from a recent pro-
spective, randomized trial of 200 patients reported by As-
cione and colleagues.12 In this study, the prevalence of
postoperative atrial arrhythmias was 49% in the conven-
tional CABG group but only 14% in the beating-heart
group. However, a criticism of this study was the high
incidence of arrhythmias in the conventional group and a
nonuniform use of -blockers.
Although the study by Mueller and colleagues1 in this
issue of the Journal reports on a very small number of
patients and lacks the statistical power to detect a meaning-
ful difference in the rates of postoperative atrial arrhythmias
between the patient groups, the authors’ observations are
important to help set the stage for further investigation. It is
a common progression in our field that anecdotal accounts
are often followed by small and then larger retrospective
studies. It is obvious that the ideal study to settle the issue
would be a prospective trial of conventional CABG versus
less invasive CABG, in which the development of postop-
erative atrial arrhythmias was an end point. Unfortunately,
as many as 1000 patients per group would be needed to have
sufficient statistical power to identify a 25% difference in
the rates of postoperative atrial arrhythmias. This would be
a monumental undertaking, but only rigorous prospective
clinical investigation will resolve many of the outstanding
issues related to the occurrence of postoperative atrial ar-
rhythmias.
Real progress in this area will not occur until targeted
laboratory investigation better elucidates the underlying
mechanisms of postoperative atrial arrhythmias. After al-
most 50 years of open cardiac surgery, the prevention of one
of the most common postoperative complications remains
elusive. Postoperative atrial arrhythmias remain a vexing
clinical problem crying for meticulous, carefully controlled
laboratory and clinical research. Ideally, cardiac surgeons
will rise to this challenge in the coming decade and finally
develop an effective therapy based on a firm mechanistic
foundation to prevent this common cause of patient mor-
bidity after cardiac surgery.
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